Having systemic lupus erythematosus may affect life expectancy.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the involvement of multiple organs and systems and the presence of a large number of autoantibodies in the body of the patient. The treatment is mainly based on medication, and the manifestation and process of the disease are quite diverse, which, if not treated in time, will cause irreversible damage to the affected organs and eventually lead to death.
With the improvement of medical technology, the survival and quality of life of SLE patients have been significantly improved after standardized and timely treatment. However, if patients are not treated in a timely manner and their disease is not under good control, their life expectancy will be affected.
SLE patients can go to the rheumatology and immunology departments of regular hospitals for detailed consultation and treatment as prescribed by doctors.